Investigating MEK Inhibition in the Treatment of Multiple Myeloma.pdf (5.16 MB)
Investigating MEK inhibition in the treatment of multiple myeloma
thesis
posted on 2019-01-10, 03:12 authored by JAY JOHN HOCKINGMultiple myeloma is an incurable haematologic malignancy. This thesis examines the use of a new medication that targets a specific mutation present in multiple myeloma. We show this treatment is effective in a subset of myeloma, and its effects enhanced when used in combination with existing treatments. This medication offers a new treatment options for a subset of multiple myeloma patients.